Matches in SemOpenAlex for { <https://semopenalex.org/work/W2950644927> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W2950644927 abstract "The treatment for recurrent and metastatic head and neck cancer is limited and prognosis is poor. Survival is limited to months and patients have significant and severe symptoms and poor quality of life.Recent phase II and III studies have shown modest benefit in survival when using checkpoint blockade in this setting with most of the studies focusing on patients heavily pretreated with chemotherapy. Initial biomarker work from these studies support a potential benefit for biomarker selection with PDL-1 and TMB with patients showing an increased and more sustained response when selected for these biomarkers. The overall response rate in an unselected patient population is less than 20 percent and that could potentially be doubled with a more robust biomarker selected patient population. the ideal ”immunologic profile” to select patients remain elusive though and more work is necessary to answer this question. The addition of chemotherapy to immunotherapy is an interesting concept and could play a role in augmenting the response rates to immunotherapy but data in head and neck cancer is lacking at this stage. Recently disclosed data in the first line setting is very encouraging and could lead to immunotherapy replacing chemotherapy in the first line recurrent and metastatic disease. the focus on a “combined immunologic score“ as a strong biomarker for survival is in keeping with what the second line data was hinting at. Going forward we expect more data looking at combination immunotherapy agents and more biomarker driven studies as is currently being done in a number of solid tumors. It has become increasingly clear that the single agent, unselected patient approach, is not necessarily ideal to improve overall outcome for the head and neck cancer patient and more work is needed to identify responders early on so that we can avoid unnecessary and costly treatments for those who are not going to benefit from this approach." @default.
- W2950644927 created "2019-06-27" @default.
- W2950644927 creator A5080875822 @default.
- W2950644927 date "2018-10-20" @default.
- W2950644927 modified "2023-09-23" @default.
- W2950644927 title "Immunotherapy and head and neck cancer: Focus on recurrent and metastatic disease" @default.
- W2950644927 doi "https://doi.org/10.18416/cio.2018.1810004" @default.
- W2950644927 hasPublicationYear "2018" @default.
- W2950644927 type Work @default.
- W2950644927 sameAs 2950644927 @default.
- W2950644927 citedByCount "0" @default.
- W2950644927 crossrefType "journal-article" @default.
- W2950644927 hasAuthorship W2950644927A5080875822 @default.
- W2950644927 hasConcept C121608353 @default.
- W2950644927 hasConcept C126322002 @default.
- W2950644927 hasConcept C143998085 @default.
- W2950644927 hasConcept C185592680 @default.
- W2950644927 hasConcept C2776530083 @default.
- W2950644927 hasConcept C2776694085 @default.
- W2950644927 hasConcept C2777701055 @default.
- W2950644927 hasConcept C2779134260 @default.
- W2950644927 hasConcept C2781197716 @default.
- W2950644927 hasConcept C2908647359 @default.
- W2950644927 hasConcept C55493867 @default.
- W2950644927 hasConcept C71924100 @default.
- W2950644927 hasConcept C99454951 @default.
- W2950644927 hasConceptScore W2950644927C121608353 @default.
- W2950644927 hasConceptScore W2950644927C126322002 @default.
- W2950644927 hasConceptScore W2950644927C143998085 @default.
- W2950644927 hasConceptScore W2950644927C185592680 @default.
- W2950644927 hasConceptScore W2950644927C2776530083 @default.
- W2950644927 hasConceptScore W2950644927C2776694085 @default.
- W2950644927 hasConceptScore W2950644927C2777701055 @default.
- W2950644927 hasConceptScore W2950644927C2779134260 @default.
- W2950644927 hasConceptScore W2950644927C2781197716 @default.
- W2950644927 hasConceptScore W2950644927C2908647359 @default.
- W2950644927 hasConceptScore W2950644927C55493867 @default.
- W2950644927 hasConceptScore W2950644927C71924100 @default.
- W2950644927 hasConceptScore W2950644927C99454951 @default.
- W2950644927 hasIssue "1" @default.
- W2950644927 hasLocation W29506449271 @default.
- W2950644927 hasOpenAccess W2950644927 @default.
- W2950644927 hasPrimaryLocation W29506449271 @default.
- W2950644927 hasRelatedWork W2020741551 @default.
- W2950644927 hasRelatedWork W2083952230 @default.
- W2950644927 hasRelatedWork W2091951796 @default.
- W2950644927 hasRelatedWork W2109887943 @default.
- W2950644927 hasRelatedWork W2124615602 @default.
- W2950644927 hasRelatedWork W2124718942 @default.
- W2950644927 hasRelatedWork W2124767573 @default.
- W2950644927 hasRelatedWork W2150375803 @default.
- W2950644927 hasRelatedWork W2150536704 @default.
- W2950644927 hasRelatedWork W2156619573 @default.
- W2950644927 hasRelatedWork W2166546697 @default.
- W2950644927 hasRelatedWork W2279139042 @default.
- W2950644927 hasRelatedWork W2422991246 @default.
- W2950644927 hasRelatedWork W2472402392 @default.
- W2950644927 hasRelatedWork W2777961796 @default.
- W2950644927 hasRelatedWork W2909887958 @default.
- W2950644927 hasRelatedWork W2990872255 @default.
- W2950644927 hasRelatedWork W2998955122 @default.
- W2950644927 hasRelatedWork W3161534002 @default.
- W2950644927 hasRelatedWork W3946155 @default.
- W2950644927 hasVolume "1" @default.
- W2950644927 isParatext "false" @default.
- W2950644927 isRetracted "false" @default.
- W2950644927 magId "2950644927" @default.
- W2950644927 workType "article" @default.